|
|
Article: Stem Cell Therapeutics Corp. Announces Dr. V. Wee Yong's Presentation at the 25th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis.
- Article from:
- Marketwire Canada
- Article date:
- September 11, 2009
CopyrightCOPYRIGHT 2009 Canadian Corporate News. News Provided by Comtex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CALGARY, ALBERTA, Sep 11, 2009 (Marketwire via COMTEX) -- Stem Cell Therapeutics Corp. ("SCT") (TSX VENTURE:SSS) today announced that Dr. V. Wee Yong, of the Hotchkiss Brain Institute from the University of Calgary, will be presenting on behalf of SCT at the 25th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis ("ECTRIMS") which is being held in Dusseldorf, Germany, September 9-12, 2009.
Dr. V. Wee Yong's presentation will discuss the safety and efficacy of prolactin in the animal model of multiple sclerosis ("MS"), experimental autoimmune encephalomyelitis. The result of the work Dr. Yong and his team have done, has led to ...